english: (Laughter) Because now, we've shared this molecule, just since December of last year, with 40 laboratories in the United States and 30 more in Europe -- many of them pharmaceutical companies, seeking now to enter this space, to target this rare cancer that, thankfully right now, is quite desirable to study in that industry.
non_english: (Smeh) Jer sada, pošto smo podelili ovaj molekul, samo od decembra prošle godine, 40 laboratorija iz SAD-a i još 30 iz Evrope - mnoge od njih su farmaceutske kompanije i sada pokušavaju da uđu u ovu oblast, usmerenu na ovaj retki rak koji je, upravo sada, na sreću, sasvim poželjna tema za ispitivanje u toj industriji.